![Erin Foff](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Erin Foff
Technik-/Wissenschafts-/F&E-Leiter bei
MAPLIGHT THERAPEUTICS, INC.
Vermögen: 11 Mio $ am 30.06.2026
Profil
Erin Pennock Foff is currently Chief Medical Officer at MapLight Therapeutics, Inc. since 2021.
Formerly, Dr. Foff was Executive Director-Clinical Development at ACADIA Pharmaceuticals, Inc. Education includes doctorates from Baylor College of Medicine and Sidney Kimmel Medical College.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 17.07.2026 | 298’901 ( 0.7% ) | 11 Mio $ | 30.06.2026 |
Aktive Positionen von Erin Foff
| Unternehmen | Position | Beginn |
|---|---|---|
| MAPLIGHT THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2021 |
Ehemalige bekannte Positionen von Erin Foff
| Unternehmen | Position | Ende |
|---|---|---|
| ACADIA PHARMACEUTICALS INC. | Corporate Officer/Principal | - |
Ausbildung von Erin Foff
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
5
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
ACADIA Pharmaceuticals, Inc.
 ACADIA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals drugs for treatment of central nervous system disorders | Health Technology |
Baylor College of Medicine
 Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sidney Kimmel Medical College
 Sidney Kimmel Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MapLight Therapeutics, Inc.
 MapLight Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics for debilitating central nervous system disorders | Health Technology |
